Total Payments
$817.57
2024 Payments
$52.44
Companies
10
Transactions
57
Medicare Patients
9,713
Medicare Billing
$544,857
Payment Breakdown by Category
Food & Beverage$798.15 (97.6%)
Education$19.42 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $798.15 | 55 | 97.6% |
| Education | $19.42 | 2 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $232.53 | 31 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $178.78 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $143.21 | 13 | $0 (2020) |
| Gilead Sciences Inc | $125.00 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $45.33 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $34.27 | 2 | $0 (2021) |
| Esperion Therapeutics, Inc. | $19.50 | 1 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $14.00 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.50 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $12.45 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.44 | 2 | E.R. Squibb & Sons, L.L.C. ($52.44) |
| 2023 | $33.50 | 2 | Esperion Therapeutics, Inc. ($19.50) |
| 2021 | $21.03 | 1 | AstraZeneca Pharmaceuticals LP ($21.03) |
| 2020 | $12.59 | 1 | Janssen Pharmaceuticals, Inc ($12.59) |
| 2019 | $12.45 | 1 | Regeneron Healthcare Solutions, Inc. ($12.45) |
| 2018 | $26.73 | 2 | Novartis Pharmaceuticals Corporation ($26.73) |
| 2017 | $658.83 | 48 | Novartis Pharmaceuticals Corporation ($205.80) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.18 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.26 | General |
| Category: Cardiovascular | ||||||
| 05/30/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/22/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/16/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Education | In-kind items and services | $12.45 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/11/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $119.23 | General |
| Category: Cardiovascular | ||||||
| 11/01/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/25/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/30/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.13 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,172 | 2,805 | $621,718 | $119,472 |
| 2022 | 25 | 2,500 | 3,291 | $734,108 | $143,304 |
| 2021 | 22 | 2,540 | 3,379 | $711,404 | $155,201 |
| 2020 | 25 | 2,501 | 3,130 | $616,977 | $126,880 |
Total Patients
9,713
Total Services
12,605
Medicare Billing
$544,857
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 475 | 783 | $259,686 | $59,344 | 22.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 215 | 218 | $86,328 | $10,993 | 12.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 76 | $34,808 | $10,597 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 152 | $35,783 | $7,754 | 21.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 50 | 50 | $32,576 | $7,202 | 22.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 812 | 1,078 | $95,452 | $6,415 | 6.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 62 | $10,230 | $3,943 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 31 | $13,175 | $3,296 | 25.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 41 | 41 | $6,519 | $2,261 | 34.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 20 | 21 | $9,471 | $1,822 | 19.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $7,412 | $1,372 | 18.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 18 | 18 | $8,640 | $1,002 | 11.6% |
| 93798 | Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | Office | 2023 | 16 | 32 | $1,952 | $604.65 | 31.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 55 | 56 | $5,656 | $562.33 | 9.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 52 | 54 | $1,836 | $540.96 | 29.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 22 | 23 | $2,300 | $434.24 | 18.9% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 18 | 18 | $1,746 | $330.66 | 18.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 14 | 14 | $840.00 | $285.60 | 34.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 14 | 14 | $1,358 | $271.32 | 20.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 17 | 17 | $3,434 | $228.99 | 6.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 13 | 13 | $884.00 | $171.07 | 19.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 17 | 17 | $1,632 | $39.61 | 2.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 481 | 883 | $288,744 | $67,168 | 23.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 272 | 274 | $108,504 | $14,140 | 13.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 80 | 83 | $38,109 | $12,927 | 33.9% |
About Dr. Thomas Noonan, MD
Dr. Thomas Noonan, MD is a Cardiovascular Disease healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679534572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Noonan, MD has received a total of $817.57 in payments from pharmaceutical and medical device companies, with $52.44 received in 2024. These payments were reported across 57 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($798.15).
As a Medicare-enrolled provider, Noonan has provided services to 9,713 Medicare beneficiaries, totaling 12,605 services with total Medicare billing of $544,857. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Pawtucket, RI
- Active Since 03/30/2006
- Last Updated 12/01/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1679534572
Products in Payments
- ENTRESTO (Drug) $232.53
- XARELTO (Drug) $143.21
- ELIQUIS (Drug) $126.34
- Ranexa (Drug) $125.00
- CAMZYOS (Drug) $52.44
- Lexiscan (Drug) $45.33
- FARXIGA (Drug) $21.03
- NEXLETOL (Drug) $19.50
- LifeVest (Device) $14.00
- BRILINTA (Drug) $13.24
- PRADAXA (Drug) $12.50
- PRALUENT (Biological) $12.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pawtucket
Andrew Hordes, Md, MD
Cardiovascular Disease — Payments: $11,049
Cardiovascular Disease $11,049
Christopher Luttmann, Md, MD
Cardiovascular Disease — Payments: $747.93
Cardiovascular Disease $747.93
Lauralyn Cannistra, Md, MD
Cardiovascular Disease — Payments: $262.20
Cardiovascular Disease $262.20
Dr. Suhdong Hahn, Md, MD
Cardiovascular Disease — Payments: $119.96
Cardiovascular Disease $119.96
Dr. Andrew Nowak, Md, MD
Cardiovascular Disease — Payments: $53.89
Cardiovascular Disease $53.89
Anthony Cannistra, Md, MD
Cardiovascular Disease
Cardiovascular Disease